Search research articles
Contact Us
Filters
Showing results (151-160 of 297) with videos related to
Page
of 30
Sort By:
Seminars in Arthritis and Rheumatism
|
May 3, 2016
Impaired quality of life in systemic sclerosis and patient perception of the disease: A large international survey
Camelia Frantz, Jérôme Avouac, Oliver Distler, et al.
The American Journal of Pathology
|
June 25, 2004
Targeted disruption of TGF-beta/Smad3 signaling modulates skin fibrosis in a mouse model of scleroderma
Gabriella Lakos, Shinsuke Takagawa, Shu-Jen Chen, et al.
JAMA Network Open
|
December 14, 2020
Lung Cancer Survival in Patients With Autoimmune Disease
Saya Jacob, Kian Rahbari, Kyle Tegtmeyer, et al.
Clinical and Experimental Rheumatology
|
April 21, 2023
Mental health symptoms in scleroderma during COVID-19: a Scleroderma Patient-centred Intervention Network (SPIN) cohort longitudinal study
Richard S Henry, Linda Kwakkenbos, Marie-Eve Carrier, et al.
Arthritis Research & Therapy
|
October 25, 2012
The adipokine adiponectin has potent anti-fibrotic effects mediated via adenosine monophosphate-activated protein kinase: novel target for fibrosis therapy
Feng Fang, Lei Liu, Yang Yang, et al.
ACR Open Rheumatology
|
July 19, 2022
Effect of Nintedanib on Progression of Systemic Sclerosis-Associated Interstitial Lung Disease Over 100 Weeks: Data From a Randomized Controlled Trial
Shervin Assassi, Oliver Distler, Yannick Allanore, et al.
Scientific Reports
|
August 9, 2018
An orally-active adiponectin receptor agonist mitigates cutaneous fibrosis, inflammation and microvascular pathology in a murine model of systemic sclerosis
Takashi Yamashita, Katja Lakota, Takashi Taniguchi, et al.
JCI Insight
|
September 22, 2022
Deficiency of inhibitory TLR4 homolog RP105 exacerbates fibrosis
Wenxia Wang, Swarna Bale, Bharath Yalavarthi, et al.
Annals of the Rheumatic Diseases
|
March 22, 2013
A synthetic PPAR-γ agonist triterpenoid ameliorates experimental fibrosis: PPAR-γ-independent suppression of fibrotic responses
Jun Wei, Hongyan Zhu, Kazuhiro Komura, et al.
Plos One
|
January 22, 2015
Experimentally-derived fibroblast gene signatures identify molecular pathways associated with distinct subsets of systemic sclerosis patients in three independent cohorts
Michael E Johnson, J Matthew Mahoney, Jaclyn Taroni, et al.
Page
of 30
Search research articles
Search
Showing results (151-160 of 297) with videos related to
Sort By:
Page
of 30
Seminars in Arthritis and Rheumatism
|
May 3, 2016
Impaired quality of life in systemic sclerosis and patient perception of the disease: A large international survey
Camelia Frantz, Jérôme Avouac, Oliver Distler, et al.
The American Journal of Pathology
|
June 25, 2004
Targeted disruption of TGF-beta/Smad3 signaling modulates skin fibrosis in a mouse model of scleroderma
Gabriella Lakos, Shinsuke Takagawa, Shu-Jen Chen, et al.
JAMA Network Open
|
December 14, 2020
Lung Cancer Survival in Patients With Autoimmune Disease
Saya Jacob, Kian Rahbari, Kyle Tegtmeyer, et al.
Clinical and Experimental Rheumatology
|
April 21, 2023
Mental health symptoms in scleroderma during COVID-19: a Scleroderma Patient-centred Intervention Network (SPIN) cohort longitudinal study
Richard S Henry, Linda Kwakkenbos, Marie-Eve Carrier, et al.
Arthritis Research & Therapy
|
October 25, 2012
The adipokine adiponectin has potent anti-fibrotic effects mediated via adenosine monophosphate-activated protein kinase: novel target for fibrosis therapy
Feng Fang, Lei Liu, Yang Yang, et al.
ACR Open Rheumatology
|
July 19, 2022
Effect of Nintedanib on Progression of Systemic Sclerosis-Associated Interstitial Lung Disease Over 100 Weeks: Data From a Randomized Controlled Trial
Shervin Assassi, Oliver Distler, Yannick Allanore, et al.
Scientific Reports
|
August 9, 2018
An orally-active adiponectin receptor agonist mitigates cutaneous fibrosis, inflammation and microvascular pathology in a murine model of systemic sclerosis
Takashi Yamashita, Katja Lakota, Takashi Taniguchi, et al.
JCI Insight
|
September 22, 2022
Deficiency of inhibitory TLR4 homolog RP105 exacerbates fibrosis
Wenxia Wang, Swarna Bale, Bharath Yalavarthi, et al.
Annals of the Rheumatic Diseases
|
March 22, 2013
A synthetic PPAR-γ agonist triterpenoid ameliorates experimental fibrosis: PPAR-γ-independent suppression of fibrotic responses
Jun Wei, Hongyan Zhu, Kazuhiro Komura, et al.
Plos One
|
January 22, 2015
Experimentally-derived fibroblast gene signatures identify molecular pathways associated with distinct subsets of systemic sclerosis patients in three independent cohorts
Michael E Johnson, J Matthew Mahoney, Jaclyn Taroni, et al.
Page
of 30